India grants emergency use authorization to Covaxin for 6-12 age group, Corbevax for 5-12 age group

STORY: India grants emergency use authorization to Covaxin for 6-12 age group, Corbevax for 5-12 age group DATELINE: April 27, 2022 LENGTH: 00:01:32 LOCATION: New Delhi CATEGORY: HEALTH SHOTLIST: 1. STANDUP (English): DEEPAK PRAKASH, Xinhua reporter 2. various of street views of New Delhi 3. various of AIIMS (All India Institute Of Medical Science) hospital area 4. various of India's vaccination drive STORYLINE: STANDUP (English): DEEPAK PRAKASH, Xinhua reporter "The Drugs Controller General of India (DCGI) Tuesday granted emergency use authorization to Covaxin for children between 6-12 years and Corbevax for those between 5-12 years of age." The approval has come amid an uptick in the COVID-19 cases in schools. India is witnessing the surge in COVID-19 cases again at a time when markets have been reopened, businesses returned to normalcy and travel activities resumed to the pre-pandemic levels. Schools and colleges have been open for in-person classes and there is no bar to gatherings. The approval by t

HEALTH-CORONAVIRUS/INDIA

HEALTH-CORONAVIRUS/INDIA

Students receive a dose of COVAXIN at a vaccination center setup at a school in Kolkata , India , on 3 January 2022 . Indian government has ramped up vaccination of all students and children's above 15 years of age as the country sees a rise in COVID-19 cases due to the new omicron variant of coronavirus . (Photo by Debarchan Chatterjee/NurPhoto) (Credit:Debarchan Chatterjee/NurPhoto/Kyodo News Images)